BXRX
NASDAQ:BXRX
Baudax Bio, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.baudaxbio.comipo date
Nov 14, 2019
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) tha...Show More
Earnings
Earnings Release in 18 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus